Current through Register 1531, September 27, 2024
(1)
Informed Consent, Consent to
Treatment.
(a) Upon admission to
a facility a patient shall, upon giving informed consent, receive treatment and
rehabilitation when ordered in accordance with accepted therapeutic practice.
(b) Prior to an adjudication of incapacity or invocation and affirmation of a
health care proxy, a patient retains the right to accept or refuse
treatment.
(c) Informed consent
must be documented in the patient's medical record.
(d) Extraordinary treatment, as defined by
statute or case law including, but not limited to, treatment with antipsychotic
medication, may not be administered or performed without the patient's specific
informed consent. In the case of a patient who lacks capacity to give informed
consent, such treatment may not be administered or performed without prior
review and approval by a court of competent jurisdiction or in the case of a
minor or a patient with a properly invoked healthcare proxy, the consent of his
or her legally authorized representative.
(e) For a patient who is believed to lack
capacity to give informed consent to treatment with antipsychotic medication,
and who is not being treated pursuant to consent by the parent of a minor or by
a health care agent pursuant to a properly invoked and affirmed health care
proxy, the right to refuse such medication may be overridden prior to an
adjudication of incapacity and court approval of a treatment plan only in rare
circumstances to prevent an immediate, substantial and irreversible
deterioration of the patient's mental illness. If treatment is to be continued
over the patient's objection, and the patient continues to lack capacity, then
an adjudication of incapacity and court approval of a treatment plan must be
sought.
(2)
Electroconvulsive Treatment for Patients Younger than 16 Years
Old.
(a) Electroconvulsive
treatment shall not be administered to any patient younger than 16 years old,
unless the Commissioner or designee concurs.
(b) The approval of the administration of
electroconvulsive treatments to patients younger than 16 years old shall be
based on such written recommendations and independent consultations as the
Commissioner or designee deems appropriate under the circumstances of the
individual case.
(c) The
Commissioner or designee's approval, and the basis therefore, shall become a
permanent part of the patient's record.
(3)
Routine and Preventive
Treatment. A patient shall be informed upon admission and at each
periodic review of the routine and preventive treatment that is ordinarily
performed at, or arranged by, the facility. Routine and preventive treatment
includes standard medical examinations, clinical tests, standard immunizations,
and treatment for minor illnesses and injuries. A patient who has capacity to
give informed consent regarding routine and preventive treatment may accept or
refuse such treatment, except that a refusal may be overridden by the facility
director, without special court authorization, when the treatment consists of:
(a) a complete physical examination, and
associated routine laboratory tests, required by law to be conducted upon
admission and at least annually thereafter.
(b) immunizations or treatment required by
law or necessary to prevent the spread of infection or disease.
(4)
Written Treatment
Plan.
(a) The patient has the
right to participate in the development and implementation of his or her
treatment plan.
(b) As part of the
treatment of a patient in a facility, there shall be a written assessment of
the strengths and needs of the patient and a written, multi-disciplinary
treatment plan, which shall be developed with the maximum possible
participation of the patient or the patient's legally authorized
representative.
(c) The treatment
plan, upon acceptance by the patient or his or her legally authorized
representative, shall be implemented by the facility staff in good faith within
the limits of available resources.
(d) There shall be a periodic written
assessment of treatment progress. Modifications of the treatment plan and the
rationale for such modifications shall be documented in the patient's
record.
(5)
Additional Requirements for Patients Eligible for Public School
Education.
(a) Treatment plans
for patients who are "children with special needs", as defined in M.G.L. c. 71B
shall, where appropriate, take into account the plan for providing special
education services developed in accordance with 603 CMR: Department of
Elementary and Secondary Education.
(b) Treatment plans for patients who are
eligible for public school education but who are not "children with special
needs" as defined in M.G.L. c. 71B, § 1, shall, if appropriate, and in
addition to all other requirements for treatment plans, reflect such patient's
educational needs.